Compare SNAP & KRYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SNAP | KRYS |
|---|---|---|
| Founded | 2010 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Programming Data Processing | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.6B | 9.6B |
| IPO Year | 2017 | 2017 |
| Metric | SNAP | KRYS |
|---|---|---|
| Price | $5.63 | $327.51 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 42 | 12 |
| Target Price | $7.39 | ★ $392.11 |
| AVG Volume (30 Days) | ★ 23.7M | 204.3K |
| Earning Date | 11-04-2026 | 11-02-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 35.71 | ★ 128.00 |
| EPS | N/A | ★ 3.62 |
| Revenue | ★ $824,949,000.00 | $389,130,000.00 |
| Revenue This Year | $14.78 | $31.33 |
| Revenue Next Year | $10.49 | $27.55 |
| P/E Ratio | ★ N/A | $93.08 |
| Revenue Growth | ★ 103.95 | 33.94 |
| 52 Week Low | $3.81 | $179.16 |
| 52 Week High | $9.13 | $382.54 |
| Indicator | SNAP | KRYS |
|---|---|---|
| Relative Strength Index (RSI) | 51.16 | 41.98 |
| Support Level | $5.46 | $331.79 |
| Resistance Level | $5.52 | $371.16 |
| Average True Range (ATR) | 0.22 | 9.85 |
| MACD | -0.04 | -1.37 |
| Stochastic Oscillator | 35.42 | 17.44 |
Snap is a technology company best known for its marquis social media application, Snapchat, a visual messaging application that has amassed hundreds of millions of users. The app was initially only used to communicate with family and friends through photographs and short videos (known as "Snaps"). Users can now enjoy augmented reality, or AR, lenses, content from famous creators and celebrities, updates about local events, and more. Although the app offers a paid subscription option with premium features, advertising sales produce most of the app's revenue. The firm also sells wearable devices called AR Spectacles, which can capture photos and videos overlayed with AR lenses, but these make up a small portion of Snap's overall sales.
Krystal Biotech Inc is an integrated, commercial-stage biotechnology company focused on the discovery, development, manufacturing, and commercialization of genetic medicines to treat diseases with high unmet medical needs. The company uses its patented HSV-1-based gene therapy platform to create vectors that deliver therapeutic transgenes to target cells. It possesses exclusive rights to develop, manufacture, and commercialize VYJUVEK internationally. The company operates as one operating segment focused on pharmaceutical products and manufactures, markets, and sells VYJUVEK in the United States and markets and sells VYJUVEK in the European Union, and Japan.